|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185.30 USD | -1.79% |
|
+6.21% | +43.85% |
| 06-29 | Roche takes aim at Illumina's dominance with new gene sequencing machine | RE |
| 06-29 | Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 197.48 | 220 | 207.31 |
| Spread/Res. | -4.46% | -14.24% | -8.99% |
| Spread/Supp. | +13.06% | +29.50% | +40.44% |
| Support | 166.89 | 145.7 | 134.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ILMN Stock
- Charts Illumina, Inc.
Select your edition
All financial news and data tailored to specific country editions
